Antineoplastic Combined Chemotherapy ProtocolsDoxorubicinChemotherapy, AdjuvantQuality of LifeAntineoplastic AgentsCyclophosphamideCombined Modality TherapyCisplatinAntibiotics, AntineoplasticTreatment OutcomeEtoposideBreast NeoplasmsNeoadjuvant TherapyDaunorubicinDisease-Free SurvivalVinblastineDrug Administration ScheduleNeoplasm StagingSurvival AnalysisLung NeoplasmsDrug ResistanceMethotrexatePrognosisSurvival RateBleomycinDrug Resistance, NeoplasmNaphthacenesPaclitaxelNogalamycinCarboplatinNeoplasm Recurrence, LocalTime FactorsIfosfamideTaxoidsCytarabineInduction ChemotherapyNeoplasmsDose-Response Relationship, DrugFollow-Up StudiesAntimetabolites, AntineoplasticLifeAnthracyclinesCell SurvivalMitomycinVincristineP-GlycoproteinOvarian NeoplasmsAdenocarcinomaDeoxycytidineOrganoplatinum CompoundsAntineoplastic Agents, PhytogenicHodgkin DiseaseAntineoplastic Agents, AlkylatingLeukemia P388Lymphoma, Non-HodgkinDacarbazineNeoplasm MetastasisLeukemia L1210MelphalanLeukopeniaNauseaCarmustineLomustineChemotherapy, Cancer, Regional PerfusionMitoxantroneCarcinoma, Non-Small-Cell LungSalvage TherapyClinical Trials as TopicNephrosisTransplantation, AutologousProspective StudiesOsteosarcomaCell Line, TumorRadiotherapyTesticular NeoplasmsVomitingTumor Cells, CulturedBone NeoplasmsDrug Resistance, MultipleNeutropeniaInfusions, Intra-ArterialLiver NeoplasmsRadiotherapy, AdjuvantCamptothecinMitomycinsHyperthermia, InducedColorectal NeoplasmsSarcomaStomach NeoplasmsLymphomaCarubicinSemustineNeoplasms, Germ Cell and EmbryonalKaplan-Meier EstimateApoptosisPalliative CareGranulocyte Colony-Stimulating FactorBrain NeoplasmsLymphatic MetastasisInfusions, Intravenous